Neoadjuvant PD-1 Blockade in Resectable Lung CancerPatrick M. Forde, Drew M. Pardoll, Stephen Broderick et al.|New England Journal of Medicine|2018Cited by 2.1k
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancersJustina X. Caushi, Kellie N. Smith, Taha Merghoub et al.|Nature|2021Cited by 546
Oral antibiotic use and chronic disease: long-term health impact beyond antimicrobial resistance and <i>Clostridioides difficile</i>Jessica Queen, Cynthia L. Sears, Jiajia Zhang|Gut Microbes|2020Cited by 39
514. Association Between Antibiotic Exposure and Clinical Outcomes of Immune Checkpoint InhibitionG. W. Wilson, Fyza Y. Shaikh, Jiajia Zhang et al.|Open Forum Infectious Diseases|2022Cited by 1